The Department of Health and Human Services, specifically the National Institutes of Health (NIH) and its National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for the procurement of 10X Genomics Xenium Prime Reagents, which are critical for ongoing research in spatial transcriptomics related to multiple sclerosis. The acquisition includes specific brand name supplies such as the Xenium Prime 5K Human Pan Tissue and Pathways Assay Kit and related custom gene panels, necessary for evaluating drug effects on induced pluripotent stem cell-derived cerebral organoids and human brain tissue. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by May 23, 2025, at 10:00 AM EST, and can contact Rita Davis or Tonia Alexander for further information regarding the solicitation RFQ-NIAID-25-2261175.